Nicola L. Farrington
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Molecular pharmacodynamics of amoxicillin-clavulanic acid for urinary tract infections caused by Escherichia coli.
Journal: Nature communications
Published: December 08, 2025
Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges.
Journal: International journal of pharmaceutics: X
Published: October 10, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis.
Journal: The Journal of antimicrobial chemotherapy
Published: May 13, 2025
Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness.
Journal: Antimicrobial agents and chemotherapy
Published: August 27, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa.
Journal: mBio
Published: January 18, 2024
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: March 22, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
Journal: The Journal of antimicrobial chemotherapy
Published: December 21, 2021
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Journal: The Journal of antimicrobial chemotherapy
Published: September 01, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: May 11, 2021
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.
Journal: Antimicrobial agents and chemotherapy
Published: May 27, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae.
Journal: Antimicrobial agents and chemotherapy
Published: January 28, 2020
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Journal: mBio
Published: December 05, 2019
Last Updated: 09/26/2026